Abstracts

LAIR-1: NEGATIVE REGULATOR OF SIV- SPECIFIC CD8 T CELLS DURING CHRONIC SIV INFECTION

Background: HIV-1 specific CD8 T cells play an important role in controlling HIV infection. However, during chronic HIV infection, HIV-specific CD8 T cells undergo functional exhaustion, lose effector function and fail to control viral infection.Leukocyte-associated Ig-like receptor-1 (LAIR-1), a 32 kDa transmembrane glycoprotein, is a surface molecule expressed on human peripheral blood mononuclear leukocytes and…

SARS-CoV-2 VACCINE-INDUCED T CELL RESPONSES IN CANCER PATIENTS UNDERGOING TREATMENT

Background: mRNA vaccines have proven useful in protecting vulnerable populations against SARS-CoV-2 infection. However, certain therapeutics, specifically those used in cancer treatment, reduce mRNA vaccine-induced humoral responses against SARS-CoV-2. The effects on T cell responses are not well characterized. Here, we evaluate SARS-CoV-2 spike-specific T cell responses over the course of one year in solid…

NEW ONSET AUTOIMMUNE DISEASE MORE COMMON AFTER COVID-19

Background: Viral infections including SARS-CoV-2 may trigger autoimmune disease through T-cell-mediated autoimmune response through molecular mimicry-cross-reactive T-cell recognition or bystander T-cell activation. Autoantibodies have been detected in patients with COVID-19 and some human proteins have homologous regions with SARS-CoV-2 peptides that could function as autoantigens. While there are scattered reports of various autoimmune diseases diagnosed…

ESTABLISHMENT OF HIV LATENCY AND MICROGLIOSIS IN PRIMARY HUMAN MICROGLIA CELLS

Background: In the brain, microglia are susceptible to HIV infection and can maintain the viral reservoir. Analysis of HIV latently infected microglia cells at a single-cell level is technically challenging and our understanding of the molecular mechanisms of latency establishment in microglia remains incomplete. Methods: We used pMorpheus-EGFP, a dual-reporter HIV construct, to examine latency…

THE SPIKE OF SARS-CoV-2 VARIANTS ALLOWS FOR MORE EFFICIENT COUNTERACTION OF BST2

Background: BST2/Tetherin is an interferon-stimulated gene with antiviral activity against enveloped viruses. Particularly, BST2 tethers virions at their site of assembly, preventing their release and spread. In addition to this primary role, BST2 is as an important bridge between the innate and adaptive immune system, since (i) BST2 routes tethered particles to lysosomes, which generates…

TELOMERE LENGTH IN AVIREMIC PWH: HOW DIFFERENT IS IT FROM PERSONS WITHOUT HIV?

Background: Blood telomere length (BTL) attrition is a surrogate biomarker of immunosenescence and aging associated with HIV infection. BTL recovers in long-term virologically suppressed PWH, but it is unknown if recovery is complete compared with persons without HIV Methods: Prospective 6-year observational study assessing the evolution of BTL in virologically suppressed PWH and a cross-sectional…

TRENDS IN TDR TO FIRST-LINE ANTIRETROVIRALS IN SPAIN: 2007-2021

Background: Treatment guidelines currently recommend resistance testing in the RT and protease of HIV as a part of the initial evaluation of HIV infected patients. Thus, it is of interest to evaluate the prevalence of drug resistance mutations (DRM) and, also of clinically relevant resistance. Here, we present data on trends in DRM and clinically…